Get the Stockscreener App
5.32
1.14%
0.06
After Hours:
5.33
0.010
+0.19%
Sight Sciences Inc stock is traded at $5.32, with a volume of 123.58K.
It is up +1.14% in the last 24 hours and up +10.37% over the past month.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
See More
Previous Close:
$5.26
Open:
$5.26
24h Volume:
123.58K
Relative Volume:
0.52
Market Cap:
$289.46M
Revenue:
$79.55M
Net Income/Loss:
$-37.25M
P/E Ratio:
-7.5418
EPS:
-0.7054
Net Cash Flow:
$-25.40M
1W Performance:
-2.39%
1M Performance:
+10.37%
6M Performance:
-25.91%
1Y Performance:
+55.10%
1-Day Range:
$5.15
$5.37
1-Week Range:
$5.14
$5.615
52-Week Range:
$3.11
$9.2362
Sight Sciences Inc Stock (SGHT) Company Profile
Name
Sight Sciences Inc
Sector
Industry
Phone
(415) 889-0550
Address
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
5.32 | 289.46M | 79.55M | -37.25M | -25.40M | -0.7054 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-08-25 | Upgrade | Lake Street | Hold → Buy |
| Dec-06-24 | Initiated | UBS | Buy |
| Nov-04-24 | Downgrade | Lake Street | Buy → Hold |
| Aug-21-24 | Initiated | Lake Street | Buy |
| Sep-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-12-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-12-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-10-23 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-23 | Upgrade | Stifel | Hold → Buy |
| Oct-04-22 | Initiated | Needham | Hold |
| Jul-26-22 | Initiated | Stifel | Hold |
| Feb-03-22 | Initiated | William Blair | Outperform |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
View All
Sight Sciences Inc Stock (SGHT) Latest News
Have Insiders Sold Sight Sciences Shares Recently? - simplywall.st
Sight Sciences Inc focuses on glaucoma devices as investors watch Nasdaq trading - ad-hoc-news.de
Citi Maintains Sight Sciences(SGHT.US) With Hold Rating, Raises Target Price to $6 - Moomoo
SGHT stock keeps a focus on Sight Sciences' business model. - ad-hoc-news.de
Price to earnings forward of Sight Sciences, Inc. – NASDAQ:SGHT - TradingView
Sight Sciences CTO David Badawi sells $40,858 in stock By Investing.com - Investing.com Australia
Sight Sciences CFO James Rodberg sells $36,994 in common shares By Investing.com - Investing.com Australia
Form 4 Sight Sciences Inc For: 6 July By Investing.com - Investing.com Nigeria
Sight Sciences EVP Brenton Taylor sells $15,333 in company stock - Investing.com
Sight Sciences CFO James Rodberg sells $36,994 in common shares - Investing.com
Form 144 Sight Sciences For: 6 July By Investing.com - Investing.com Nigeria
Sight Sciences COO Alison Bauerlein sells $129,626 in stock By Investing.com - Investing.com Nigeria
Sight Sciences EVP Brenton Taylor sells $15,333 in company stock By Investing.com - Investing.com South Africa
Sight Sciences CLO Jeremy Hayden sells $70,133 in stock By Investing.com - Investing.com Nigeria
Sight Sciences (SGHT) CEO’s 28,684-share tax sale and updated holdings - Stock Titan
Sight Sciences COO Alison Bauerlein sells $129,626 in stock - Investing.com UK
Sight Sciences CEO Paul Badawi disposes of $155,467 in stock - Investing.com
Sight Sciences CEO Paul Badawi disposes of $155,467 in stock By Investing.com - Investing.com India
Sight Sciences (NASDAQ: SGHT) CLO sells 12,733 shares to cover RSU taxes - Stock Titan
Sight Sciences (NASDAQ: SGHT) CFO sells 6,902 shares to cover RSU tax bill - Stock Titan
Sight Sciences (SGHT) CTO sells 7,418 shares to cover RSU tax liability - Stock Titan
Sight Sciences (SGHT) EVP sells shares to cover RSU-related tax obligations - Stock Titan
Sight Sciences (SGHT) COO sells shares to cover RSU tax, retains 664,709 stake - Stock Titan
[144] Sight Sciences, Inc. SEC Filing - Stock Titan
SGHT (NASDAQ: SGHT) affiliate files Form 144 to sell 12,733 shares - Stock Titan
Sight Sciences Inc. (SGHT) Holds Steady Near Support as Trading Volume Remains SubduedGrowth Stock Picks - dars.gov.et
Form 144 Sight Sciences For: 2 July By Investing.com - Investing.com Canada
SGHT (NASDAQ) Form 144 shows 6,902-share resale after restricted-vesting - Stock Titan
SGHT (NASDAQ) insider resale notice: 24,184 shares tied to vesting - Stock Titan
Form 144 Sight Sciences For: 1 July By Investing.com - Investing.com India
2,829 Restricted Shares for SGHT (NASDAQ: SGHT)Form 144 Notice - Stock Titan
SGHT (NASDAQ: SGHT) files notice for 28,684‑share restricted stock sale - Stock Titan
Sight Sciences, Inc. Actuals & Estimates (NASDAQ:SGHT) - TradingView
SGHT Forecast — Price Target — Prediction for 2027 - TradingView
Sight Sciences earnings calendar and glaucoma focus, shares on Nasdaq in medtech peer group - AD HOC NEWS
Sight Sciences Inc (SGHT) Institutional Confidence - TradingKey
Sight Sciences Inc (SGHT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sight Sciences Inc (SGHT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Sight Sciences Inc (SGHT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Sight Sciences Inc (SGHT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Sight Sciences Inc (SGHT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Sight Sciences Inc (SGHT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sight Sciences Inc (SGHT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sight Sciences Inc (SGHT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sight Sciences director Encrantz buys $68,793 in company stock By Investing.com - Investing.com Nigeria
Sight Sciences director Encrantz buys $68,793 in company stock - Investing.com
Sight Sciences (SGHT) director boosts direct stake with 14,100-share buy - Stock Titan
Sight Sciences | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Discover 3 Promising Penny Stocks With Market Caps Over $20M - Sahm
Number of shareholders of Sight Sciences, Inc. – NASDAQ:SGHT - TradingView
Sight Sciences Shareholders Reelect Directors, Ratify Auditor - The Globe and Mail
Sight Sciences Inc Stock (SGHT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):